drugset / Trial / NCT00920985

US Cycle Control and Blood Pressure Study

NCT00920985

Phase 3 Completed 346 enrolled Bayer
RandomizedParallel-groupDouble-blindPrevention

Summary

Birth Control Patch Study

Timeline

Start
2009-06
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Comparator Levonorgestrel Small molecule 100 ug Oral
Comparator ethinyl estradiol Small molecule 20 ug Oral
Comparator ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.